Effect of protease inhibitors on the anti-enzymatic and surface activities of bronchoalveolar contents in infectious-toxic shock
Protsenko, V.A.; Opryshko, V.V.; Shpak, S.I.; Nesterov, E.N.; Safronova, L.G.
Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 6: 49-52
1984
ISSN/ISBN: 0031-2991 PMID: 6084229 Document Number: 237383
Document emailed within 1 workday
Related Documents
Milpied-Homsi, B.; Krempf, M.; Gueglio, B.; Raffi, F.; Stalder, J.F. 1999: "Buffalo neck": an unintended secondary effect of treatment with anti-HIV protease inhibitors Annales de Dermatologie et de Venereologie 126(3): 254-256Lozitskiĭ, V.P.; Fedchuk, A.S.; Puzis, L.E.; Buĭko, V.P.; Girlia, I.I. 1987: Participation of the proteolysis system in promoting the virulence of the influenza virus and development of the infectious process; the antiviral effect of protease inhibitors Voprosy Virusologii 32(4): 413-419
Kunde, K. 2000: HIV therapy: toxic liver injuries caused by protease inhibitors? Deutsche Medizinische Wochenschrift 125(12): A12-A13
Cobo Reinoso, J.; Martín Dávila, P.; Antela López, A.; Pérez Elías, M.J. 1999: Impact of protease inhibitors on hospitalization in an Infectious Disease Unit Revista Clinica Espanola 199(8): 547-549
Vander Jagt, D.L.; Caughey, W.S.; Campos, N.M.; Hunsaker, L.A.; Zanner, M.A. 1989: Parasite proteases and antimalarial activities of protease inhibitors Progress in Clinical and Biological Research 313: 105-118
Gel'fand, B.R. 1984: Infectious-toxic shock in suppurative peritonitis Anesteziologiia i Reanimatologiia 5: 25-30
Moskaliuk, M.P.; Silina, L.V. 1987: Hemosorption in the combined therapy of infectious toxic shock Anesteziologiia i Reanimatologiia 2: 53-54
Gel'fand, B.R.; Sergeeva, N.A.; Makarova, L.D.; Chesnokova, T.T.; Bagdat'ev, V.E. 1988: Metabolic disorders in infectious-toxic shock in patients with peritonitis Khirurgiia 2: 84-88
Pauli, B.U.; Weinstein, R.S. 1982: Correlations between cell surface protease activities and abnormalities of occludens junctions in rat bladder carcinoma in vitro Cancer Research 42(6): 2289-2297
Magadula, J.J.; Tewtrakul, S. 2010: Anti-HIV-1 protease activities of crude extracts of some Garcinia species growing in Tanzania African Journal of Biotechnology 9(12): 1848-1852
Osipova, N.I.; Cherkasova, T.D.; Girshovich, M.Iu.; Avrorov, V.P.; Iurkiv, V.Iu. 1990: Glutathione and superoxide dismutase redox system in the development of toxic-infectious shock caused by Yersinia pestis toxin Biulleten' Eksperimental'noi Biologii i Meditsiny 109(2): 156-158
Pokrovskiĭ, V.I.; Radzivil, G.G.; Beloborodov, V.B.; Broniakin, I.V.; Roslyĭ, I.M. 1986: Role of hemosorption in the therapy of infectious toxic shock and the multiple-organ failure syndrome in a fulminating form of meningococcemia Terapevticheskii Arkhiv 58(9): 117-122
Postelmans, L.; Gerard, M.; Sommereijns, B.; Caspers, L.; Clumeck, N.; Libert, J. 1997: Impact of anti-retroviral treatment with protease inhibitors on the evolution of cytomegalovirus retinitis in the patient carrying acquired immunodeficiency syndrome Bulletin de la Societe Belge d'Ophtalmologie 267: 133-144
Armignacco, O.; Andreoni, M.; Sagnelli, E.; Puoti, M.; Bruno, R.; Gaeta, G.Battista.; Perno, C.F.; Santantonio, T.A.; Bonfanti, P.; Bonora, S.; Borderi, M.; Castagna, A.; d'Arminio Monforte, A.; De Luca, A.; Grossi, P.; Guaraldi, G.; Maggiolo, F.; Mussini, C.; Sagnelli, C.; Tavio, M.; Torti, C.; Uberti-Foppa, C.; Andreoni, M.; Angarano, G.; Antinori, A.; Armignacco, O.; Carosi, G.; Chirianni, A.; Di Perri, G.; Galli, M.; Lazzarin, A.; Rizzardini, G.; Sagnelli, E.; Taliani, G. 2014: Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease new microbiologica 37(4): 423-438
Tierno, P.M.; Hanna, B.A. 1989: Ecology of toxic shock syndrome: amplification of toxic shock syndrome toxin 1 by materials of medical interest Reviews of Infectious Diseases 11(Suppl 1): S182
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Atrio, J.; Stek, A.; Vora, H.; Sanchez-Keeland, L.; Zannat, F.; Natavio, M. 2015: The effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 20(2): 149-153
Mariani, E.; Stefanini, G.F.; Ferruzzi, A.; Garagnani, M.; Facchini, A. 1979: Surface immunoglobulins (SmIg) in human B-lymphocytes: effect of enzymatic digestion Bollettino della Societa Italiana di Biologia Sperimentale 55(5): 411-416
Jablonická, K.; Kovalcík, V. 1979: Changes in some enzymatic parameters in the serum of rats under tourniquet shock and the effect of histamine and antihistaminics Bratislavske Lekarske Listy 71(6): 641-648